Kelly Kearney
Director, Investor Relations and Communications
Sachin Patel, MD, PhD
SAB Member
Dr. Patel leads the Anxiety Disorder program at Psy Therapeutics. He brings 15 years of experience in cannabinoid neurobiology to the Psy team to develop novel treatments for major psychiatric disorders. His expertise ranges from clinical practice and education to translational research in the areas of neurobiology and neuropharmacology.
Dr. Patel’s work has been supported by a variety of federal agencies, non-profit institutions and companies. He is a well-recognized expert in the cannabinoid field and has published more than 50 research articles on the topic. He holds leadership positions in several international research organizations focused on cannabinoid biology and has served as a content expert for a number of national organizations focused on understanding the health and biological effects of cannabinoids and cannabis. His research has focused on identifying novel targets for the treatment of mood and anxiety disorders and has discovered new biological mechanisms that regulate stress-related bio-behavioral processes relevant to major affective disorders.
He received his undergraduate degree from the University of California, Santa Barbara, in Biological Psychology and his MD and PhD from the Medical College of Wisconsin and completed his clinical residency in adult psychiatry at Vanderbilt University. He is currently The Lizzie Gilman Professor of Psychiatry and Behavioral Sciences at Northwestern University Feinberg School of Medicine.
